SK bioscience Co.,Ltd. (302440.KS)
KRW 54700.0
(-5.36%)
KRW 54700.0
(-5.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 369.5 Billion | 456.72 Billion | 929 Billion | 225.61 Billion | 183.93 Billion | 88.17 Billion |
| Cost of Revenue | 227.26 Billion | 217.11 Billion | 358.71 Billion | 130.26 Billion | 106.07 Billion | 48.95 Billion |
| Gross Profit | 142.24 Billion | 239.61 Billion | 570.28 Billion | 95.34 Billion | 77.85 Billion | 39.21 Billion |
| Operating Expenses | 154.23 Billion | 124.59 Billion | 96.06 Billion | 57.63 Billion | 55.06 Billion | 24 Billion |
| Selling, General and Administrative Expenses | 60.81 Billion | 27.31 Billion | 15.73 Billion | 12.83 Billion | 13.36 Billion | 7.03 Billion |
| Research and Development Expenses | 85.74 Billion | 57.95 Billion | 47.25 Billion | 25.98 Billion | 27.71 Billion | 10.51 Billion |
| Other Expenses | - | 39.32 Billion | 33.07 Billion | 18.81 Billion | 13.98 Billion | -480.8 Million |
| Cost and Expenses | 381.49 Billion | 341.71 Billion | 454.78 Billion | 187.9 Billion | 161.14 Billion | 72.96 Billion |
| Operating Income | -4.73 Billion | 115.01 Billion | 474.21 Billion | 37.71 Billion | 22.79 Billion | 15.2 Billion |
| Interest Expense | 1.39 Billion | 2.46 Billion | 3.42 Billion | 4.15 Billion | 4.18 Billion | 2.42 Billion |
| Income Tax Expense | -14.99 Billion | 19.28 Billion | 115.98 Billion | 4.4 Billion | 3.8 Billion | 443.14 Million |
| Earnings before Tax | 7.32 Billion | 141.73 Billion | 471.12 Billion | 37.29 Billion | 18.48 Billion | 863.99 Million |
| Net Income | 22.31 Billion | 122.45 Billion | 355.13 Billion | 32.88 Billion | 14.67 Billion | 420.84 Million |
| Earnings Per Share Basic | 291.00 | 1596.18 | 4642.34 | 429.93 | 191.86 | 209.93 |
| Earnings Per Share Diluted | 289.79 | 1589.84 | 4642.34 | 429.93 | 191.86 | 209.93 |
| Weighted Average Shares Outstanding | 76.69 Million | 76.71 Million | 76.5 Million | 76.5 Million | 76.5 Million | 2 Million |
| Weighted Average Shares Outstanding (Diluted) | 77.01 Million | 77.02 Million | 76.5 Million | 76.5 Million | 76.5 Million | 2 Million |
| Gross Margin | 0.38 | 0.52 | 0.61 | 0.42 | 0.42 | 0.44 |
| EBIT Margin | 0.06 | 0.36 | 0.54 | 0.27 | 0.19 | 0.24 |
| Profit Margin | 0.06 | 0.27 | 0.38 | 0.15 | 0.08 | 0.00 |
| EBITDA | 22.77 Billion | 142.25 Billion | 492.99 Billion | 57.97 Billion | 37.21 Billion | 21.1 Billion |
| Earnings Before Tax Margin | -0.01 | 0.25 | 0.51 | 0.17 | 0.12 | 0.17 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 61.64 Billion | 26.77 Billion | 22.27 Billion | 90.6 Billion | 369.5 Billion | 231.82 Billion |
| Cost of Revenue | - | 10.38 Billion | 18.56 Billion | 62.92 Billion | 233.1 Billion | 126.34 Billion |
| Gross Profit | 61.64 Billion | 16.38 Billion | 3.71 Billion | 27.68 Billion | 136.4 Billion | 105.48 Billion |
| Operating Expenses | 101.26 Billion | 44.46 Billion | 39.01 Billion | 38.75 Billion | 179.92 Billion | -44.54 Billion |
| Selling, General and Administrative Expenses | - | 14.15 Billion | 14.34 Billion | 17.19 Billion | - | 44.54 Billion |
| Research and Development Expenses | - | 29.8 Billion | 24.47 Billion | 21.12 Billion | - | 24.87 Billion |
| Other Expenses | -101.26 Billion | -502.21 Million | -188.65 Million | -435.01 Million | -1.41 Billion | -89.08 Billion |
| Cost and Expenses | 101.26 Billion | 54.85 Billion | 57.57 Billion | 101.67 Billion | 413.03 Billion | 126.34 Billion |
| Operating Income | -39.61 Billion | -28.07 Billion | -35.3 Billion | -11.07 Billion | -43.52 Billion | 60.93 Billion |
| Interest Expense | - | 238.35 Million | 262.04 Million | 261.41 Million | 1.82 Billion | 201.07 Million |
| Income Tax Expense | -8.34 Billion | -5.49 Billion | -6.08 Billion | -564.69 Million | -14.99 Billion | 10.23 Billion |
| Earnings before Tax | -30.65 Billion | -16.9 Billion | -19.8 Billion | 3.6 Billion | 7.32 Billion | 58.62 Billion |
| Net Income | -22.31 Billion | -11.4 Billion | -13.71 Billion | 4.16 Billion | 22.31 Billion | 48.39 Billion |
| Earnings Per Share Basic | -290.48 | -148.50 | -178.56 | 54.30 | - | 630.23 |
| Earnings Per Share Diluted | -290.48 | -148.50 | -178.12 | 54.14 | - | 630.23 |
| Weighted Average Shares Outstanding | 76.82 Million | 76.82 Million | 76.82 Million | 76.79 Million | 76.78 Million | 76.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 76.82 Million | 76.82 Million | 77.01 Million | 77.21 Million | 77.01 Million | 76.78 Million |
| Gross Margin | 1.00 | 0.61 | 0.17 | 0.31 | 0.37 | 0.46 |
| EBIT Margin | -0.64 | -0.71 | -1.18 | -0.02 | - | 0.46 |
| Profit Margin | -0.36 | -0.43 | -0.62 | 0.05 | 0.06 | 0.21 |
| EBITDA | -39.61 Billion | -18.99 Billion | -26.17 Billion | -1.97 Billion | - | 105.48 Billion |
| Earnings Before Tax Margin | -0.64 | -1.05 | -1.59 | -0.12 | -0.12 | 0.26 |
VIT
WJRYF
NCTY
MCB
301018
ARC